Cargando…
NF-κB in Cancer Immunity: Friend or Foe?
The emergence of immunotherapies has definitely proven the tight relationship between malignant and immune cells, its impact on cancer outcome and its therapeutic potential. In this context, it is undoubtedly critical to decipher the transcriptional regulation of these complex interactions. Followin...
Autores principales: | Lalle, Guilhem, Twardowski, Julie, Grinberg-Bleyer, Yenkel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914614/ https://www.ncbi.nlm.nih.gov/pubmed/33572260 http://dx.doi.org/10.3390/cells10020355 |
Ejemplares similares
-
A T cell-intrinsic function for NF-κB RelB in experimental autoimmune encephalomyelitis
por: Lalle, Guilhem, et al.
Publicado: (2021) -
Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?
por: Stéphan, Pierre, et al.
Publicado: (2020) -
Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κB
por: Lubrano di Ricco, Martina, et al.
Publicado: (2020) -
The immune system in cancer metastasis: friend or foe?
por: Janssen, Louise M.E., et al.
Publicado: (2017) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)